Karl Marquez

Title: The Innovative Contributions of Karl Marquez

Introduction

Karl Marquez is a notable inventor based in San Diego, California. He has made significant contributions to the field of immunology, particularly in the development of novel methods for preparing natural killer (NK) cells. With a total of two patents to his name, Marquez is recognized for his innovative approaches that enhance the efficiency of cell preparation processes.

Latest Patents

Marquez's latest patents focus on the preparation of mononuclear cell-derived NK cells. These NK cells are derived from cord blood or peripheral blood mononuclear cells without the need to isolate CD34+ hematopoietic stem cells or NK cells, and without the requirement for a feeder layer. The methods he has developed utilize an enrichment process that incorporates antiCD16 agonist antibodies, antiCD3 antibodies, and N-803. Notably, these processes are designed to be adaptable into a fully automated production process, referred to as "GMP in a box."

Career Highlights

Karl Marquez is currently employed at ImmunityBio, Inc., where he continues to advance his research and development efforts. His work is pivotal in the field of immunotherapy, contributing to the understanding and application of NK cells in clinical settings.

Collaborations

Marquez collaborates with esteemed colleagues such as Rohit Duggal and Ranjeet Sinha, who share his commitment to innovation in immunology. Their combined expertise fosters a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

In summary, Karl Marquez is a distinguished inventor whose work in the preparation of NK cells is paving the way for advancements in immunotherapy. His contributions are not only innovative but also hold the promise of transforming treatment methodologies in the medical field.